Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988.
about
BotulismTreatment of neuroterrorismBioterrorism and the nervous system.Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin.Diversity of proteolytic Clostridium botulinum strains, determined by a pulsed-field gel electrophoresis approachWhat next for botulism vaccine development?Clostridium botulinum: a bug with beauty and weapon.Management of botulism.Fatal course of foodborne botulism in an eight-month old infant.SYBR green real-time PCR method to detect Clostridium botulinum type A.Botulism type E outbreak associated with eating a beached whale, AlaskaBotulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pHNewly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typingFoodborne botulism in Canada, 1985-2005Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.Case 2: An infant with hypotonia and constipation.Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodiesSynthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors.Botulism, where are we now?Type E botulism.Endemic foodborne botulism among Alaska Native persons--Alaska, 1947-2007.Development of a Cell-Based Functional Assay for the Detection of Clostridium botulinum Neurotoxin Types A and E.International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice.Black Tar Heroin Skin Popping as a Cause of Wound Botulism.Neuro-ophthalmic findings in botulism type B.Accuracy of a Mouse Bioassay for the Diagnosis of Botulism in Horses.Takotsubo-like Myocardial Dysfunction in a Patient with Botulism.Botulism mortality in the USA, 1975-2009.Picolinic acids as β-exosite inhibitors of botulinum neurotoxin A light chain.Botulinum neurotoxin type B uses a distinct entry pathway mediated by CDC42 into intestinal cells versus neuronal cells.Botulism in Brazil, 2000-2008: epidemiology, clinical findings and laboratorial diagnosis.Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity.Clinical Characteristics and Ancillary Test Results Among Patients With Botulism-United States, 2002-2015.Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.Foodborne botulism due to ingestion of home-canned green beans: two case reports.Clinical Features of Foodborne and Wound Botulism: A Systematic Review of the Literature, 1932-2015.Wound botulism in injecting drug users.A Novel Rabbit Spirometry Model of Type E Botulism and its Use for the Evaluation of Post-symptom Antitoxin Efficacy.Wound botulism in drug addicts in the United Kingdom.
P2860
Q21994439-11FA8564-88EA-4773-A179-2F7E03209FAAQ30224792-B0C1EEB3-2E75-4C70-93C7-51C80685576FQ30233372-A967F6D9-BC33-434B-90A5-CD7029487CD6Q33617935-56073411-CAA4-408D-B835-C5A4ECBBE0DEQ33716433-2FBB1144-D21F-4C4A-A634-D1558E83233DQ34343808-E8242049-F2DE-4AC0-95B6-0ED0AE2871CFQ34412430-8C25CA6D-8BE0-47B5-AE88-40506A19E1C5Q35035105-CB4F45AB-5E08-40E6-BBB3-33B6A58FF3C7Q35768460-C6987431-EC7E-4E94-A4A6-21259A8C567FQ35844362-C72B2877-3605-4AB4-8044-E9C4CFC5C451Q35872896-342F7FCF-4F27-4B81-8942-4EC61DEFF0C8Q36099792-910E662E-3AC8-4407-BCD9-CEE793B1C173Q36223269-020FC1BF-8DC7-4545-A135-29098FB44D51Q36925712-F532E213-6398-4113-B1BA-4A1603A7FC5EQ37020480-F3B19636-81A1-40AE-B7BF-4C1D409F12D8Q37128417-F1665DD6-EC4D-41A7-910E-9C2CE5F37605Q37289350-B9BAB1A4-4F98-495F-9D96-0BF704DC972DQ37308221-20BA26FB-F0F7-4E76-A2D1-5E534B4C7FCDQ37366811-9B179D38-80AB-45F2-8DCF-3BD4CE0B234CQ37822447-E1688A97-B8C7-4F2D-8835-46C499814EEAQ37822448-5F945A44-A466-4722-9CEB-BECBDBF7EC3BQ37835557-0862B33D-FE15-46E3-8A38-E039C39AE949Q39243951-7FBA8678-3603-42B3-AB5E-F7936BD86F57Q40039382-C28DDF8C-89A6-4F98-AE59-3A42281F433BQ40189607-410643A8-4C75-4605-9B2D-AEB6514106E7Q40600114-13472723-8DBF-43EE-A185-8833A5E20708Q41531593-074DB68F-372E-432E-A16F-5F8450D68FACQ41996707-F00CC08A-25B8-4D04-9493-D8EBD68D44F4Q42219106-7507CBD0-88F2-4C6C-88C4-B02AD238B9A6Q42378309-E9922E7D-69BA-44B1-9017-AD57286D5CF2Q42506921-E0CA8E23-4849-4B18-9AB2-344E9641815EQ43331672-D10B3118-5BE3-4278-AE04-F551F36B61F9Q46575974-DA53636C-C7E2-4639-9A82-9DFEECB99A7AQ47222973-025B2BE3-6812-42C1-8992-7FF8D4A6E366Q47373283-59B15D88-B7B6-4272-826F-795FFC7AEC95Q47665378-D845739F-0061-43A1-AC3C-A61AB5A4542DQ47666831-BE3ECB70-3631-4679-B998-B2FB8C7DBAD9Q49160270-CF9F0E7A-2B5D-4FDA-9E51-AF48768FFDC9Q50044361-68BDB067-B58D-4CAD-9D8E-40AB04A4914EQ51367103-B2675D55-D0B7-47FF-8E57-5C32306ABCD4
P2860
Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Clinical and laboratory compar ...... the United States, 1975-1988.
@en
Clinical and laboratory compar ...... the United States, 1975-1988.
@nl
type
label
Clinical and laboratory compar ...... the United States, 1975-1988.
@en
Clinical and laboratory compar ...... the United States, 1975-1988.
@nl
prefLabel
Clinical and laboratory compar ...... the United States, 1975-1988.
@en
Clinical and laboratory compar ...... the United States, 1975-1988.
@nl
P2093
P356
P1476
Clinical and laboratory compar ...... the United States, 1975-1988.
@en
P2093
Griffin PM
Hatheway CL
Hutwagner LC
McCroskey LM
Wainwright RB
Woodruff BA
P304
P356
10.1093/INFDIS/166.6.1281
P407
P577
1992-12-01T00:00:00Z